Announcement

Collapse
No announcement yet.

Antimicrob Agents Chemother. Cell culture-selected substitutions in influenza A(H3N2) neuraminidase affect drug susceptibility assessment

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Antimicrob Agents Chemother. Cell culture-selected substitutions in influenza A(H3N2) neuraminidase affect drug susceptibility assessment

    [Source: Antimicrobial Agents and Chemotherapy, full page: (LINK). Abstract, edited.]


    Cell culture-selected substitutions in influenza A(H3N2) neuraminidase affect drug susceptibility assessment

    Daisuke Tamura 1,2, Ha T. Nguyen 1,3, Katrina Sleeman 1, Marnie Levine 1,3, Vasiliy P. Mishin 1, Hua Yang 1, Zhu Guo 1, Margaret Okomo-Adhiambo 1, Xiyan Xu 1, James Stevens 1 and Larisa V. Gubareva 1*

    Author Affiliations: <SUP>1</SUP>Virus Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA <SUP>2</SUP>Oak Ridge Institute for Science and Education, Oak Ridge (ORISE), Tennessee, USA <SUP>3</SUP>Battelle Memorial Institute, Atlanta, Georgia, USA.


    ABSTRACT

    Assessment of drug susceptibility has become an integral part of influenza virus surveillance. In this study, we describe the drug resistance profile of influenza A(H3N2) virus, A/Mississippi/05/2011, collected from a patient treated with oseltamivir and detected via surveillance. An MDCK-grown isolate of this virus exhibited highly reduced inhibition by the neuraminidase (NA) inhibitors (NAIs) oseltamivir (8005-fold), zanamivir (813-fold), peramivir (116-fold), and laninamivir (257-fold) in the NA inhibition assay. Sequence analysis of its NA gene revealed a known oseltamivir-resistance marker, the glutamic acid-to-valine substitution at position 119 (E119V), and an additional change, threonine-to-isoleucine at position 148 (T148I). Unlike E119V, T148I was not detected in the clinical sample but acquired during viral propagation in MDCK cells. Using recombinant proteins, T148I by itself was shown to cause only a 6-fold increase in zanamivir-IC<SUB>50</SUB> and had no effect on inhibition by others. The T148I substitution reduced NA activity by 50%, most likely by affecting positioning of the 150-loop at the NA catalytic site. Using the pyrosequencing, changes at T148 were detected in 35 (23%) of 150 MDCK-grown A(H3N2) viruses tested, which was lower than the frequency of changes at D151 (85%), a NA residue previously implicated in cell selection. We demonstrate that culturing of the A(H3N2) viruses (n=11) at a low multiplicity of infection delayed the emergence of the NA variants with changes at 148 and/or 151, especially when conducted in MDCK-SIAT1 cells. Our findings highlight the current challenges in monitoring susceptibility of influenza A(H3N2) viruses to the NAI class of antiviral drugs.


    FOOTNOTES

    * Corresponding author. Mailing address: Mail Stop G-16, 1600 Clifton Road, Atlanta, GA, 30333, Phone: (404) 639-3204. Fax: (404) 639-0080. E-mail: lqg3@cdc.gov.

    Copyright 2013, American Society for Microbiology. All Rights Reserved.


    -
    ------
Working...
X